IP Library Granted Patent US 8,084,206
Granted Patent B2
US 8,084,206 · App. 12/439,061 · Granted Dec 27, 2011

High speed, high fidelity, high sensitivity nucleic acid detection

Assignee: Arizona Board of Regents, a body corporate acting for and on behalf of Arizona State University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,084,206
App. No.
12/439,061
Granted
Dec 27, 2011
Kind
B2
Abstract

The present invention provides methods, compositions, and kits for nucleic acid detection.

Claims (21)

1. A method for detecting a target nucleic acid, consisting essentially of:

(a) contacting a plurality of target-specific nucleic acid probes that are each complementary to a target nucleic acid, to a sample under conditions whereby the plurality of target-specific nucleic acid probes hybridize to the target nucleic acid if the target nucleic acid is present in the sample, wherein upon hybridization to the target nucleic acid, the target-specific nucleic acid probes form a series of target-specific nucleic acid probes directly adjacent to one another, wherein a first target specific nucleic acid probe is capable of binding or is bound to a molecular post and a second target-specific nucleic acid probe is capable of binding or is bound to a detection probe, and wherein the first target-specific nucleic acid probe and the second target-specific nucleic acid probe are positioned at the 5′ and 3′ end, respectively, of the series of target specific nucleic acid probes;

(b) binding the molecular post to the first target-specific nucleic acid probe and/or binding the detection probe to the second target-specific nucleic acid probe if the molecular post and/or detection probe were not bound prior to hybridization;

(c) ligating the series of target-specific nucleic acid probes together to produce a ligation product;

(d) after ligating then binding the molecular post to the first target-specific nucleic acid probe and/or binding the detection probe to the second target-specific nucleic acid probe and forming a concentration gradient of ligation products prior to contacting the ligation products with the molecular post and/or detection probe;

(e) treating the ligation product with one or both of:

(i) exonuclease digestion; and

(ii) denaturation to create all single stranded bridges after ligation;

(f) binding the molecular post to the first target-specific nucleic acid probe and/or binding the detection probe to the second target-specific nucleic acid probe if the molecular post and/or detection probe were not bound prior to the step (e) treatment; and

(g) then detecting the ligation product.

2. The method of claim 1 , wherein the step (e) treatment comprises exonuclease digestion.

3. The method of claim 1 , wherein the step (e) treatment comprises denaturation.

4. The method of claim 1 wherein the plurality of target specific nucleic acid probes comprises at least 3 target specific nucleic acid probes.

5. The method of claim 1 wherein the plurality of target specific nucleic acid probes comprises at least 5 target specific nucleic acid probes.

6. The method of claim 1 wherein the ligation comprise ligation chain reaction.

7. The method of claim 1 , wherein the molecular post comprises a magnetic particle.

8. The method of claim 7 , further comprising applying a magnetic field to move the ligation product.

9. The method of claim 1 wherein the molecular post is immobilized for detection.

10. The method of any claim 1 , wherein the detecting comprises fluorescence microscopy, surface plasmon resonance, gel electrophoresis, calorimetric shifts, electric conductivity or autoradiography.

11. The method of claim 1 wherein the sample is selected from the group consisting of synthetic nucleic acids, genomic DNA, cell lysates, tissue homogenates, forensic samples, environmental samples, and isolated nucleic acid samples.

12. The method of claim 1 wherein the target nucleic acid comprises double stranded DNA.

Assignments (5)
CONFIRMATORY LICENSE Recorded Sep 16, 2019
From: ARIZONA STATE UNIVERSITY - TEMPE CAMPUS
To: NATIONAL INSTITUTES OF HEALTH; AIR FORCE OFFICE OF SCIENTIFIC RESEARCH
Reel/Frame 050388/0533 →
CONFIRMATORY LICENSE Recorded Nov 12, 2013
From: ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031625/0951 →
CONFIRMATORY LICENSE Recorded Feb 16, 2011
From: ARIZONA STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025801/0046 →
CORRECTIVE ASSIGNMENT TO CORRECT THE DOCKET NUMBER: PREVIOUSLY RECORDED ON REEL 022981 FRAME 0402. ASSIGNOR(S) HEREBY CONFIRMS THE 06-276-PCT-US. Recorded Jul 22, 2009
From: FRASCH, WAYNE; SPETZLER, DAVID; YORK, JUSTIN
To: ARIZONA BOARD OF REGENTS, A BODY CORPORATE ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 022991/0511 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2009
From: FRASCH, WAYNE; SPETZLER, DAVID; YORK, JUSTIN
To: ARIZONA BOARD OF REGENTS, A BODY CORPORATE ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 022981/0402 →
Continuity (2)
Provisional Application 60841007 · Aug 30, 2006
Related Publication 20100015616A1 · Jan 21, 2010